An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...

T he Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold ...

Now, new research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized ...

Scientists have developed a nasal Alzheimer's disease vaccine that they believe could be key to preventing and treating the degenerative cognitive condition in humans. The vaccine, which blocks a ...